Friday, April 6, 2018

BRIEF-U.S. FDA Observes Alembic Pharma Failed To Review Any Unexplained Discrepancy On Inspection Of Co's Panelav Plant - CNBC TV18

* USFDA OBSERVES ALEMBIC PHARMA FAILED TO REVIEW ANY UNEXPLAINED DISCREPANCY AFTER INSPECTION OF CO'S PANELAV PLANT ON MARCH 12-20 -CNBC TV18
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)